Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recipharm has appointed Yves Buelens to the position of General Manager for its wholly owned new subsidiary Kaysersberg Pharmaceuticals SAS.
read more
Tuesday, January 11, 2022
Recipharm announced the sale to Astrea Pharma, the newly established CDMO provider focused on small molecule oral solid and aseptic dosages, of the solid dose manufacturing site at Fontaine-lès-Dijon, France.
read more
Wednesday, December 14, 2016
Recipharm has appointed Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and Europe.
read more
Recipharm Karlskoga AB, specialized in the manufacture of semi-solid products, and Pharmanest
AB, a Stockholm-based pharmaceutical company specializing in developing products for local pain
relief in obstetrics and gynecology, are pleased to ...
read more
Wednesday, December 16, 2015
Recipharm and LIDDS have signed an exclusive collaboration agreement regarding scale-up of the production process and commercial manufacture of Liproca® Depot, LIDDS patented targeted treatment for prostate cancer.
read more
Wednesday, December 07, 2016
Recipharm is entering into collaboration with Laccure AB for the commercial manufacture and delivery of Laccure® Pessary.
read more
Friday, February 18, 2022
Recipharm announced the acquisition of Vibalogics, a virotherapy CDMO and a portfolio company of Ampersand Capital Partners. Vibalogics manufactures oncolytic viruses, viral vaccines and gene therapies, offering process and analytical development, ...
read more
Recipharm will acquire Sanofi’s contract inhalation drug business and plant in the U.K.
read more
Recipharm has completeted the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company with a turnover in 2014 of close to SEK 29 million that is specialized in medicinal chemistry offering synthesis and ...
read more
Thursday, November 20, 2014
The Pharmaceutical Contract Development and Manufacturing Organisation, Recipharm AB (publ) has acquired Lisbon based CDMO Lusomedicameta Sociedade Técnica Farmacêutica S.A.
read more
Global contract development and manufacturing organisation (CDMO), Recipharm, announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, ...
read more
Recipharm has achieved the new ISO 45001 certification at its Wasserburg facility in Germany.
read more
11 June 2013 - Recipharm AB is pleased to announce that it is working with Vectura Group plc to provide access to its licence for the regulatory dossier of Asmasal® for the Chinese regulatory authorities as part of the Chinese market approval process...
read more
Tuesday, January 21, 2025
ReciBioPharm, a division of Recipharm, has been awarded a three-year grant from the Bill & Melinda Gates Foundation (Gates Foundation). The funding will support the global deployment of xRNA Continuous Manufacturing technologies to LMICs.
read more
La Loma, Tlalnepantla, Mexico, Real Clean Distribuciones SA de CV is voluntarily recalling all lots four hand sanitizers it manufactured.
read more